New Cardiovascular Horizons (NCVH)
Avatar

Sirolimus Eluting Stents BTK: Outcomes and Safety

By New Cardiovascular Horizons (NCVH) FEATURING Sohail Khan
By New Cardiovascular Horizons (NCVH) FEATURING Sohail Khan
79 views
July 24, 2019
Comments 0
Login to view comments. Click here to Login

Related Videos

02:28
Boston Scientific

Impact of the IMPERIAL Trial

Feat. M. Jaff, W. Gray, R. Lookstein, S. Henao, G. Ansel
03:43
Boston Scientific

The Design of a Drug-Eluting Stent System

02:12
Boston Scientific

IMPERIAL Trial: Influencing Treatment Algorithms

Feat. S. Henao, M. Jaff, W. Gray, R. Lookstein, G. Ansel
01:02
Boston Scientific

Dr. Lookstein IMPERIAL 2-Year Data

Feat. R. Lookstein
01:40
Boston Scientific

IMPERIAL Trial: First of its Kind Design

Feat. W. Gray, R. Lookstein, M. Jaff
01:46
Boston Scientific

The Challenges of the SFA

02:37
Boston Scientific

Drug-Eluting Stents: The Heritage

Feat. G. Ansel, M. Jaff, R. Lookstein, J. Diaz-Cartelle
03:13
Boston Scientific

Drug-Eluting Stents: The Breakthrough

Feat. A. Holden, W. Gray, R. Lookstein, T. Zeller
02:37
Boston Scientific

Drug-Eluting Stents: The Challenge

Feat. L. Garcia, M. Jaff, R. Lookstein
52
Boston Scientific

Boston Scientific Drug-Eluting Technologies

Feat. R. Sachar
14:09

What Is the Future of Drug-Eluting Technologies?

ARCH Advanced Revascularization Symposium

E. Dippel

264 views
03:20
Boston Scientific

Drug-Eluting Stents: The Solution

Feat. J. Granada, M. Montero-Baker, A. Holden, G. Ansel
02:58
Boston Scientific

Drug-Eluting Stents: The Data

Feat. J. Diaz-Cartelle, R. Lookstein, L. Garcia
09:09

Bioresorbable Technology in Below-the-Knee Intervention

NY Endovascular Summit

S. Parikh

130 views
15:07

Below the Knee Therapies: State of the Art

ARCH Advanced Revascularization Symposium

V. Kapur

273 views
23:45

Subacute Occlusion Left SFA - Leipzig, Germany - LINC 2019

NY Endovascular Summit

A. Schmidt

220 views
09:29
Boston Scientific

Clinical Update in Drug Eluting Technologies for PAD

Feat. P. Monteleone
11:25

Treatment of Femoral-Popliteal Disease: What Are the Factors that Ne…

ARCH Advanced Revascularization Symposium

A. Thomas

782 views
17:27

Paclitaxel or Limus: What Is the Future in Drug Eluting Therapies?

ARCH Advanced Revascularization Symposium

C. Walker

1.5K views
20:01

What Stent to Use 2019

ARCH Advanced Revascularization Symposium

J. Singh

966 views
AUTOPLAY